Influence of melphalan plus fludarabine-conditioning regimen in elderly patients aged ⩾55 years with hematological malignancies

Bone Marrow Transplant. 2016 Jan;51(1):157-60. doi: 10.1038/bmt.2015.235. Epub 2015 Oct 5.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Allografts
  • Disease-Free Survival
  • Female
  • Hematologic Neoplasms / mortality*
  • Hematologic Neoplasms / therapy*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Melphalan / administration & dosage*
  • Middle Aged
  • Retrospective Studies
  • Survival Rate
  • Transplantation Conditioning*
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives*

Substances

  • Vidarabine
  • fludarabine
  • Melphalan